Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Gross Margin: 2010-2024

Historic Gross Margin for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -43.84%.

  • China Pharma Holdings' Gross Margin rose 3935.00% to -7.89% in Q3 2025 from the same period last year, while for Sep 2025 it was -10.94%, marking a year-over-year increase of 2340.00%. This contributed to the annual value of -43.84% for FY2024, which is 3983.00% down from last year.
  • As of FY2024, China Pharma Holdings' Gross Margin stood at -43.84%, which was down 993.62% from -4.01% recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Gross Margin peaked at 17.97% during FY2020, and registered a low of -43.84% during FY2024.
  • For the 3-year period, China Pharma Holdings' Gross Margin averaged around -17.98%, with its median value being -6.09% (2022).
  • Its Gross Margin has fluctuated over the past 5 years, first surged by 440bps in 2020, then tumbled by 3,983bps in 2024.
  • Over the past 5 years, China Pharma Holdings' Gross Margin (Yearly) stood at 17.97% in 2020, then tumbled by 1,435bps to 3.62% in 2021, then plummeted by 972bps to -6.09% in 2022, then skyrocketed by 209bps to -4.01% in 2023, then slumped by 3,983bps to -43.84% in 2024.